The Impact of Intense-pulsed Light and Modified Kligman’s Formula for Management of the Moderate to Severe Melasma: A Comparative Study

Ali Mozan Dhahir Elethawi *

Department of Dermatology and Venereology, College of Medicine, University of Sulaymaniyah, Iraq.

Fahim Thabit Al-Gurairi

Department of Dermatology, AL-Mahmoodyha General Hospital, Iraq.

*Author to whom correspondence should be addressed.


Background: Melasma is a common pigmentary disorder that poses therapeutic challenges, so a variety of treatment modalities have been used in targeting pigmentation of melasma such as laser, Intense-pulsed light (IPL) and topical depigmented agents.

Objective: To compare the efficacy and safety of Intense-pulsed light (IPL) with modified kligman formula (triple combination) versus IPL alone in the treatment of melasma.

Methods: Forty-one patients with melasma (20 group-A and 21 group -B) were selected, mostly of skin type III, IV and V.  Treatment is performed by using a session of IPL then daily use modified kligman formula at night and glycerin cream as moisturizer in the morning and with use of sunscreen in group -A for 4 sessions while group -B patients were treated by IPL alone at 4-week intervals. All the patients were photographed before starting the therapy and at the end of four IPL sessions. 

Results: Most of the patients in both groups had showed a good improvement in their melasma with the use of our treatment with adequate sun protection. The Melasma Area and Severity Index (MASI) scores significantly decreased in both groups after the treatment especially in epidermal types and also mixed types though no statistical difference was established among final MASI values of patients with dermal type in group-B.

Conclusion:  The use of IPL sessions and triple mixture cream seems to be more effective than IPL sessions alone.  It is an easy and a good option for patients with melasma. Adverse effects were minimal and acceptable with good satisfaction rate among patients.

Keywords: Intense-pulsed light, triple mixture, modified Kingman’s formula, melasma, IPL

How to Cite

Elethawi , Ali Mozan Dhahir, and Fahim Thabit Al-Gurairi. 2024. “The Impact of Intense-Pulsed Light and Modified Kligman’s Formula for Management of the Moderate to Severe Melasma: A Comparative Study”. Journal of Advances in Medicine and Medical Research 36 (2):1-8.


Download data is not yet available.


Tamega AD, Miot LD, Bonfietti C, Gige TC, Marques ME, Miot HA. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. Journal of the European Academy of Dermatology and Venereology. 2013;27 (2):151-6.

Handel AC, Lima PB, Tonolli VM, Miot LD, Miot HA. Risk factors for facial melasma in women: a case-control study. Br J Dermatol. 2014;171(3):588–594

Handel AC, Miot LD, Miot HA Melasma: A clinical and epidemiological review Ann Bras Dermatol 2014;89:771–82

Rajanala S, Maymone MBC, Vashi NA. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies. Dermatol Online J. 2019;15;25(10).

Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46(2):111–116.

Esposito ACC, Brianezi G, de Souza NP, Miot LDB, Miot HA. Exploratory study of epidermis, basement membrane zone, upper dermis alterations and Wnt pathway activation in melasma compared to adjacent and retroauricular skin. Ann Dermatol. 2020;32(2):101–108.

Muhammad Yousif Saeed, Ali M. Dhahir Elethawi, Hawzheen Aziz Hama. Efficacy and Safety of Yellow Light Diode Laser 577nm for Treatment of Melasma Patients in Sulaymaniyha City. The Iraqi Post Graduate Medical Journal. 2016;15(3):365-371

Dharni R, Madke B, Singh AL. Correlation of clinicodermatoscopic and Wood's lamp findings in patients having melasma. Pigment International. 2018;5(2):91-5.

Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, Nordlund JJ, Rendon M, Taylor S, Gottschalk RW, Agim NG. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. Journal of the American Academy of Dermatology. 2011;64(1):78-83.

Kwon SH, Na JI, Choi JY, Park KC. Melasma: Updates and perspectives. Exp Dermatol. 2019;28:704-8.

Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol. 2013;14(5):359- 76.

Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009;28 (2):77-85.

Chan R, Park KC, Lee MH, Lee ES, Chang SE, Leow YH, et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159:697–703

G Zoccali, D Piccolo, P Allegra, M Giuliani. Melasma Treated with Intense-pulsed light. Aesthetic Plastic Surgery 2010;34(4):486–93.

Lisa Zaleski, Sbrina Fabi MD, Mitchel P. Goldman MD. Treatment of 15 melasma and the use of intense-pulsed light: A review. J Drugs Dermatol. 2012;11(11): 1316-1230.

Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. International Journal of Women's Dermatology. 2017;3(1):11-20.

Baron ED, Harris L, Redpath WS, Shapiro H, Hetzel F, Morley G, Bar-Or D, Stevens SR. Laser assisted penetration of topical anesthetic in adults. Arch Dermatol. 2003; 139(10):1288–90.